Two Injective ETF filings from Canary Capital and 21Shares move into SEC review

Two exchange-traded funds tied to Injective have been filed by Canary Capital and 21Shares, and the proposals are now under review by the U.S. Securities and Exchange Commission, according to Cointelegraph Decentralization Guardians.